According
to a study by “The Center for Public Policy”, a non-partisan public interest
think tank in Washington D.C., it is estimated that a record $120 million was
spent lobbying for health reform. In addition to direct lobbying, some of
the top firms also rewarded members of Congress with campaign contributions
through political action committees and individual lobbyist donations.
The largest of these firms, Patton Boggs LLP, contributed more than $55,000
almost exclusively to Democrats.
Patton
Boggs represents Bristol-Myers Squibb, one of the largest pharmaceutical
companies in the nation and the eighth largest corporation in the United
States. The other top firms that participated (along with a list of the
companies they represent) are as follows:
Capitol
Hill Strategies:
Amgen—the nation’s largest biotechnology firm
BIO—a multi-million dollar biotechnology firm
Merck—the largest pharmaceutical company in the world
Pharmaceutical Researchers and Manufacturers of America [PHARMA] – a trade group representing pharmaceutical and biotechnology companies
BIO—a multi-million dollar biotechnology firm
Merck—the largest pharmaceutical company in the world
Pharmaceutical Researchers and Manufacturers of America [PHARMA] – a trade group representing pharmaceutical and biotechnology companies
Grover
Park Group:
Blue
Cross—a federation of 39 health
insurance organizations
Pfizer—a pharmaceutical company, ranking number one in sales in the world
Duberstein Group:
Pfizer—a pharmaceutical company, ranking number one in sales in the world
Duberstein Group:
Novartis—a pharmaceutical company ranking number one
in revenues and three in sales
Sanofi-Aventis—a pharmaceutical company that ranks number four in sales worldwide
Sanofi-Aventis—a pharmaceutical company that ranks number four in sales worldwide
Mehlman,
Vogel, Castagnetti:
Humana—the fourth largest health insurance company
in the United States
Abbott Laboratories—a multi-billion dollar pharmaceuticals healthcare company
General Electric—multi-billion dollar corporation dealing in many health related sectors
Abbott Laboratories—a multi-billion dollar pharmaceuticals healthcare company
General Electric—multi-billion dollar corporation dealing in many health related sectors
Elmendorf
strategies:
UnitedHealth
Group—the nation’s largest health
insurance company
Heather
Podesta & Partners:
Cigna—the nation’s fifth largest health insurance
company
Eli Lilly—a multi-billion dollar pharmaceutical company that ranks tenth in sales
Eli Lilly—a multi-billion dollar pharmaceutical company that ranks tenth in sales
Of
the over 17,000 lobbyists in Washington D.C., The Center for Public Integrity
ranks Patton Boggs as numero uno. In terms of healthcare reform, they are
followed by Alston and Bird, who represent Aetna, the nation’s third largest
health insurer. Coming in at number three is Foley Hoag, who also represents
Pfizer as well as Eli Lilly, Amgen and Merck. Tied for fourth place are
Podesta Group and Capitol partners. Dutko Worldwide rounds out the top
five and they also lobbied for UnitedHealth, PhRMA, and medical device firm
Medtronic Inc.
Of
those lobbying firms’ big name clients, Pharmaceutical Researchers and
Manufacturers of America alone spent $26.1 million lobbying for Obamacare in
2009, making it the single most expensive lobbying effort in history. During
the week leading up to the vote on the legislation, PhRMA launched a multi-million
dollar ad blitz in 43 districts of potential swing Democrats to help secure
passage. And in this election cycle, PhRMA has contributed $30,300 to
Dem’s compared to $13,000 to Repub’s. Overall, PhRMA has spent well over
$100 million on ad campaigns promoting health care reform legislation.
According to his bio, PhRMA’s outgoing CEO Billy Tauzin ”was a key player in 2009 healthcare reform negotiations that produced
pharmaceutical industry support for White House and Senate efforts. Reportedly,
proposals for Medicare Part D cost reductions and permitting drug importation
from Canada were dropped in favor of $80 billion in other savings.” He
helped write the bill.
The
largest health insurance providers in the nation are UnitedHealth Group,
WellPoint, Aetna, Humana and Cigna. Ever since the healthcare
debate began over a year ago, shares of Cigna, UnitedHealth Group and
WellPoint have been up an average of 120%. Upon passage of the bill, health
insurer’s stocks soared with Aetna hitting a 52 week high. The share
price of Cigna surged 375% compared to 46% for the stock market overall (as
measured by the S&P 500) since November 2008. It should be
noted that Aetna has been a major supporter and campaign contributor to the
campaigns of Max Baucus (D-MT) of the Senate Finance Committee who received
$56,250 in donations and Senator Joe Lieberman (I-CT) who received
$110,000. Todd M. Schoenberger, Managing Editor of
“Taipan’s Tipping Point Alert” wrote recently that “One day following a vote in favor of healthcare reform legislation,
stocks turned higher led by the healthcare sector. Despite the concern of many
Wall Street analysts, any negative sentiment surrounding the healthcare sector
about higher taxes and pressure on bottom lines quickly subsided as everything
from managed care to medical device stocks traded higher with heavy volume.”
Hospital
shares also surged. The day after the House passed the bill, shares of Health
Management Associates, Tenet Healthcare and Community Health
Systems all jumped 11%, 9%, and 6% respectively.
It
should be clear by now that the major players in the healthcare industry
overwhelmingly lobbied in support of Obamacare and have and will continue to
reap vast rewards. So then you may ask who exactly is this great villain
the Democrats have dubbed as the evil “health insurance industry”? The
name that consistently comes up is America’s Health Insurance Plans
(AHIP). “America’s Health
Insurance Plans (AHIP)
is a national political advocacy and trade association with about 1,300 member
companies that sell health insurance coverage to more than 200 million
Americans and is thereby funded by the premiums they pay.” AHIP representatives
attended meetings at the White House and Congress and were instrumental in
negotiating language in the bill.
This was an insurance company bill.